|
Patterns of depressive symptoms among survivors of early-stage breast cancer (BC). |
|
|
Expert Testimony - Kephren; techspert.io |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Gilead Sciences |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - GlaxoSmithKline |
Consulting or Advisory Role - Pierre Fabre |
Research Funding - Amgen Foundation (Inst); GlaxoSmithKline; GlaxoSmithKline |
|
|
|
|
|
Consulting or Advisory Role - Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Pfizer |
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca |
Travel, Accommodations, Expenses - MSD Oncology; Viatris |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca; BMSi; Daiichi Sankyo Europe GmbH; Eisai; Lilly; MSD Oncology; Novartis; Pfizer; Roche; Seagen |
Consulting or Advisory Role - AstraZeneca; BMSi; Daiichi Sankyo Europe GmbH; Eisai; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Roche; Seagen |
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca/Daiichi Sankyo (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Chugai Pharma; Eisai; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Biophytis; IQvia; Kedrion Biopharma; Roche; SERVIER; Yuhan |
|
|
Speakers' Bureau - Novartis (Inst) |
Research Funding - Resilience Care (Inst); Resilience Care (Inst) |
|
|
No Relationships to Disclose |